Search
Search Funnelback University
- Refined by:
- Date: 2024
61 -
64 of
64
search results for news |u:mitocamb.medschl.cam.ac.uk
Fully-matching results
-
[11C]PK11195 PET as a biomarker to diagnose and monitor natural…
https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/measuring-studies/11cpk11195-pet-as-a-biomarker-to-diagnose-and-monitor-natural-history-in-mitochondrial-disease/23 Feb 2024: Loading. Menu. Menu. Search. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease. Status: Open to -
Understanding the progression over time of hereditary spastic…
https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/understanding-studies/understanding-the-progression-over-time-of-hereditary-spastic-paraplegia-hsp-ataxia-and-related-conditions-prospax/23 Feb 2024: Loading. Menu. Menu. Search. Understanding the progression over time of hereditary spastic paraplegia (HSP), ataxia and related conditions (PROSPAX). Understanding the progression over time of hereditary spastic paraplegia (HSP), ataxia and related -
DefINe: A randomised, double-blind, placebo-controlled trial…
https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/define-a-randomised-double-blind-placebo-controlled-trial-examining-the-safety-and-efficacy-of-deferiprone-in-patients-with-neuroferritinopathy/23 Feb 2024: Loading. Menu. Menu. Search. DefINe: A randomised, double-blind, placebo-controlled trial examining the safety and efficacy of deferiprone in patients with neuroferritinopathy. DefINe: A randomised, double-blind, placebo-controlled trial examining -
OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense…
https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/osprey-study-a-phase-i-open-label-study-to-investigate-antisense-oligonucleotide-stk-002-in-patients-with-adoa/23 Feb 2024: Loading. Menu. Menu. Search. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense Oligonucleotide STK-002 in Patients with ADOA. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense Oligonucleotide STK-002 in Patients
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
- postgraduate entry requirements |u:mi.eng.cam.ac.uk (0) · moments ago
Recent searches
Your search history is empty.